MabSelect™ mild elution (launched in October 2025)

Description

We are pleased to introduce MabSelect™ mild elution, a Protein A resin designed for the capture of antibodies that are sensitive to acidic pH. Its key advantage is a milder elution, typically around pH ~5 (vs. ~pH 3.5–4 traditionally), in order to reduce acid-induced aggregation, improve yields, and preserve biological activity as much as possible. Delivers value in: • Reducing aggregation and yield loss during the capture of pH-sensitive antibodies by limiting exposure to highly acidic conditions. • Improving the quality of the capture pool and potentially reducing the burden on polishing steps. • Leveraging the Fc-specific interaction to separate product-related impurities already at the capture step when purifying asymmetric bispecific antibodies with a knockout of the Protein A–Fc interaction motif on one chain. Key features: • Mild elution at pH ~5: designed to limit aggregation and loss of biological activity of the sample. • Strong productivity (DBC): capacity of approximately 60 g/L at 6 min residence time (RT). • Reusability across many cycles: a caustic stability study is available. • Available for both research and industrial applications.

Presented by

Other offers from The partner